Access to Medicines
Congress should reject the 12-14.5 year monopoly for biologic products provided for in HR 1548
KEI* opposes H.R.1548, the bill to “establish a pathway for the licensure of biosimilar biological products,” on the grounds that the period of the monopoly is excessive, and not subject to safeguards that would protect consumers.
At the WIPO Conference on Intellectual Property and Public Policy Issues today, Margaret Chan, the Director General of the World Health Organization, made the following speech at WIPO’s Conference on Intellectual Property and Public Policy Issues on the topic of “Strengthening Multilateral Cooperation on IP and Public Health” where she shared the limelight with Pascal Lamy, Director General of the World Trade Organ
Note: Only a portion of the speech is reproduced here.
Special Event on Africa and the Least Developed Countries:
Partnerships and Health
(1130 – 1330 hrs, 8 July 2009, Geneva
Intervention by Hono’ble Minister of State for External Affairs, Smt. Preneet Kaur
Hon’ble Co-Chairs/Madam Moderator, Distinguished Delegates,
Pope Benedict XVI encyclical letter denounces excessive zeal for assertions of intellectual property rights in knowledgeSubmitted by Staff on 6. July 2009 - 22:00
Pope Benedict XVI today issued a statement saying that “On the part of rich countries, there is excessive zeal for protecting knowledge through an unduly rigid assertion of the right to intellectual property, especially in the field of health care.” The criticism came in a section of his most recent encyclical letter dealing with social issues, and specifically focusing on international human development and systemic failures of bodies large and small to solve development problems.
The World Health Organization just published a report on this week’s second meeting of the WHO Expert Working Group (EWG) on R&D Financing.
Press Advisory: NGO letters to WHO & WTO on Dutch seizures of generic medicines in-transit from India to Brazil, Colombia & PeruSubmitted by thiru on 19. February 2009 - 5:32
February 19, 2009
Press Advisory on NGO letters to WHO and WTO on topic of Dutch seizures of generic medicines in-transit from India to Brazil, Colombia and Peru.
In response to news about four seizures of generic medicines manufactured in India and shipped through the Netherlands in route to Brazil, Colombia and Peru, sixteen public health, consumer and development NGOs have sent separate letters to the heads of the World Health Organization (WHO) and the World Trade Organization (WTO).
Today I am at Harvard, attending a workshop titled: Unbranding Medicines: the politics, promise, and challenge of generic drugs. This is put on by the Harvard Interfaculty Initiative on Medicines and Society. The program in general is quite impressive, particularly as regards to the depth of experience and knowledge about the generic drug industry, including its early origins.
I was asked to speak about the use of prizes. The slides from my presentation are here:
KEI has been researching and advocating for the collective management of Intellectual Property Rights and the use of patent pools to promote both new innovation and access to medicines.
Worth reading first
March 8, 2007, Recent examples of the use of compulsory licensing of patents, revised March 31, 2007.